Literature DB >> 7645251

Long-term production of rotavirus antibody and protection against reinfection following a single infection of neonatal mice with murine rotavirus.

M M McNeal1, R L Ward.   

Abstract

It has been found that mice infected with murine rotavirus can be protected against subsequent murine rotavirus infection for up to 2 months. It was also reported that protection against rotavirus infection in adult mice correlated with serum and stool rotavirus IgA titers. The present study was conducted to determine the duration of rotavirus antibody production and protection against rotavirus infection in this mouse model and its possible correlation with rotavirus antibody titers. It was found that protection of mice against subsequent infection following a single oral immunization with the murine rotavirus strain EDIM was 100% effective for at least 14 months, most of the lifetime of a mouse. During this period, serum and stool rotavirus antibody titers which included serum IgA, IgG, and neutralizing antibody to EDIM, as well as stool IgA, remained elevated. Of particular note, stool rotavirus IgA titers gradually decreased to levels that were approximately 10% of their peak at 1 month after infection but did not decrease further, while serum rotavirus IgG titers continuously increased during the 14 months of the study. Serum rotavirus IgA titers varied from month to month but overall remained relatively constant throughout the 14-month period. Thus, both serum and stool rotavirus antibody was retained at substantial levels long after a single rotavirus immunization in the absence of reexposure, and mice remained protected against reinfection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7645251     DOI: 10.1006/viro.1995.1429

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities.

Authors:  M M McNeal; M N Rae; R L Ward
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 2.  Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity.

Authors:  M K Slifka; R Ahmed
Journal:  Trends Microbiol       Date:  1996-10       Impact factor: 17.079

Review 3.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 4.  The regulation of gut mucosal IgA B-cell responses: recent developments.

Authors:  N Y Lycke; M Bemark
Journal:  Mucosal Immunol       Date:  2017-07-26       Impact factor: 7.313

5.  Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice.

Authors:  S Ishida; N Feng; B Tang; J M Gilbert; H B Greenberg
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

6.  Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infections.

Authors:  M Ciarlet; M K Estes; C Barone; R F Ramig; M E Conner
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

7.  Extraintestinal spread and replication of a homologous EC rotavirus strain and a heterologous rhesus rotavirus in BALB/c mice.

Authors:  M Fenaux; M A Cuadras; N Feng; M Jaimes; H B Greenberg
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

8.  Expression of the mucosal homing receptor alpha4beta7 correlates with the ability of CD8+ memory T cells to clear rotavirus infection.

Authors:  J R Rosé; M B Williams; L S Rott; E C Butcher; H B Greenberg
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

9.  Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles.

Authors:  M M McNeal; M N Rae; J A Bean; R L Ward
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

10.  Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.

Authors:  A H Choi; M Basu; M M McNeal; J D Clements; R L Ward
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.